MacFarlane, David
4 papers on CoChat
Most cited papers
- Verified
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 3,163
- Verified
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet
Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes
Cited by 638
- Verified
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology
Adipokines, Inflammation, and Metabolic DiseasesLipid metabolism and biosynthesis
Cited by 385
- Verified
Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct
Stimson, R. H., Anderson, A. J., Ramage, L. E., Macfarlane, D. P., de Beaux, A. C., Mole, D. J., Andrew, R., & Walker, B. R. (2017) · Diabetes, Obesity and Metabolism
Lipid metabolism and biosynthesisAdipokines, Inflammation, and Metabolic Diseases
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free